TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program June 4, 2010
TCL Archive NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts April 3, 1992
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010